Synonyms: example 45 [WO2010056563A1] | GLXC26326 | LY-2780301 | LY2780301
Compound class:
Synthetic organic
Comment: GLXC-26326 is a clinical stage AKT1/2/3 and ribosomal protein S6 kinase B1 (p70S6; RPS6KB1) kinase inhibitor [1].
|
|
References |
1. Dally RD, Joseph S, Shepherd TA. (2010)
Akt and p70 s6 kinase inhibitors. Patent number: WO2010056563A1. Assignee: Eli Lilly And Company. Priority date: 03/11/2009. Publication date: 20/05/2010. |